Pathogenesis of Invasive Pulmonary Aspergillosis in Transplant Recipients
Purpose of Review Transplant patients are at high risk for invasive pulmonary aspergillosis, and the associated mortality is high. The purpose of this study is to review the pathogenesis of invasive pulmonary aspergillosis (IPA) in transplant patients. Recent Findings The pathogenesis of aspergillosis is multifactorial and results from a complex interplay between the pathogen and host. It is well recognized that Aspergillus causes IPA in immunocompromised patients. Recent studies have shown that Aspergillus might also cause diseases likely attributed to an unmodulated immune response in certain transplant recipients such as bronchopulmonary aspergillosis or bronchiolitis obliterans syndrome in lung transplant recipients. Summary This review focuses on two crucial axes of the damage response framework applicable to aspergillosis: (1) Aspergillus virulence attributes that enable it to survive and proliferate in the host (thermotolerance, stress and hypoxic response, secretion of secondary metabolites) and (2) host response with specific focus on innate immunity and angiogenesis..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Current fungal infection reports - 11(2017), 4 vom: 27. Juni, Seite 148-157 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Samanta, Palash [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Damage response framework |
---|
Anmerkungen: |
© Springer Science+Business Media New York 2017 |
---|
doi: |
10.1007/s12281-017-0278-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR024759716 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR024759716 | ||
003 | DE-627 | ||
005 | 20230519182956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12281-017-0278-5 |2 doi | |
035 | |a (DE-627)SPR024759716 | ||
035 | |a (SPR)s12281-017-0278-5-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Samanta, Palash |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pathogenesis of Invasive Pulmonary Aspergillosis in Transplant Recipients |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Springer Science+Business Media New York 2017 | ||
520 | |a Purpose of Review Transplant patients are at high risk for invasive pulmonary aspergillosis, and the associated mortality is high. The purpose of this study is to review the pathogenesis of invasive pulmonary aspergillosis (IPA) in transplant patients. Recent Findings The pathogenesis of aspergillosis is multifactorial and results from a complex interplay between the pathogen and host. It is well recognized that Aspergillus causes IPA in immunocompromised patients. Recent studies have shown that Aspergillus might also cause diseases likely attributed to an unmodulated immune response in certain transplant recipients such as bronchopulmonary aspergillosis or bronchiolitis obliterans syndrome in lung transplant recipients. Summary This review focuses on two crucial axes of the damage response framework applicable to aspergillosis: (1) Aspergillus virulence attributes that enable it to survive and proliferate in the host (thermotolerance, stress and hypoxic response, secretion of secondary metabolites) and (2) host response with specific focus on innate immunity and angiogenesis. | ||
650 | 4 | |a Invasive pulmonary aspergillosis |7 (dpeaa)DE-He213 | |
650 | 4 | |a pathogenesis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Damage response framework |7 (dpeaa)DE-He213 | |
650 | 4 | |a Transplant recipients |7 (dpeaa)DE-He213 | |
700 | 1 | |a Hong Nguyen, M. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current fungal infection reports |d Philadelphia, Pa. : Current Medicine Group, 2007 |g 11(2017), 4 vom: 27. Juni, Seite 148-157 |w (DE-627)SPR024755729 |w (DE-600)2421752-9 |x 1936-377X |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2017 |g number:4 |g day:27 |g month:06 |g pages:148-157 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12281-017-0278-5 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 11 |j 2017 |e 4 |b 27 |c 06 |h 148-157 |